Redox-responsive engineered hybrid nanomedicine for gallbladder cancer therapy via hyaluronic acid depletion

Author:

Zou Jinglin,Jiang Cong,Li Xianglong,Zhong Tianyu,Wang Shuqi,Wang Bo,Zhang DapengORCID,Hao Ji-Na,Cao Yuanyuan,Guan Mengjia,Zhang Peng,Dai Bin,Li Yongsheng

Publisher

Elsevier BV

Subject

General Materials Science

Reference38 articles.

1. Cancer.Net Editorial Board, Gallbladder cancer: statistics, 2022. https://www.cancer.net/cancer-types/gallbladder-cancer/statistics. (Accessed 02 2022). This website describes the details about the five-year survival rate of gallbladder cancer: “... The 5-year survival rate tells you what percent of people live at least 5 years after the cancer is found. Percent means how many out of 100. The 5-year survival rate for people with gallbladder cancer is 19%. ...”.

2. Gallbladder cancer: lessons from a rare tumour;Wistuba;Nat. Rev. Cancer,2004

3. Biliary tract cancer: on the way to a personalized therapy;Sinn;Deut. Med. Wochenschr,2020

4. A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract;Graham;BMC Res. Notes,2016

5. Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: the CORGI-U study;Gunnlaugsson;Radiother. Oncol.,2010

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3